Store

Home | Store | Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025

Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025

Publication Date: June 12, 2025

SKU: 25-071KA

Tags: Blood Banking, Cardiovascular Disease, Diagnostics Market Research, Genetic Diseases, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, IVD, Market Share, Market Size, Oncology and Cancer, POC, Point of Care, Respiratory Diseases, Test Categories

Pages: 460

SKU: 25-071KA

Kalorama Information’s new report, Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025, provides an in-depth analysis of one of the most pivotal segments of the in vitro diagnostics (IVD) industry with market estimates and forecasts spanning 2024-2029. Immunoassays—diagnostic tests that detect target analytes via antibody-antigen interactions—are foundational tools in clinical laboratories and point-of-care (POC) settings, enabling the detection of proteins, hormones, drugs, and infectious agents.

The global immunoassay market continues to expand, driven by advances in automation, miniaturization, multiplexing, and biomarker discovery. Despite being a mature technology, immunoassays are evolving rapidly to meet modern healthcare needs—from central labs to self-testing applications.

Market Segmentation

By Setting

  • Centralized Lab-Based Immunoassays:
    • Used in core labs for diagnostics, monitoring, and screening.
    • Market Sales: Major contributors include infectious diseases, cardiac markers, and tumor markers.
    • Top segments covered:
      • Infectious Disease
      • Cardiac Markers
      • Metabolic Disorders & Hormones
      • Tumor Markers
      • Autoimmune & Allergy Testing
  • Point-of-Care (POC) Immunoassays:
    • Includes lateral flow and other rapid tests in hospitals, clinics, retail settings, and self-testing.
    • Rapidly growing due to ease of use and decentralized access.
    • Top segments covered:
      • Infectious Disease
      • Hormone/Fertility
      • Cardiac Markers
      • Oncology & FOBT
      • Toxicology

Breakout By Disease Category

  • Infectious Disease: Largest and most diverse segment; includes tests for HIV, hepatitis, MRSA, STDs, COVID-19, and TORCH.
  • Cardiac Markers: Strong growth from heart failure and acute care testing.
  • Hormones & Fertility: High usage in both labs and POC; includes reproductive and thyroid hormones.
  • Oncology/Tumor Markers: Focus on PSA, CEA, CA-125, AFP with lab-based dominance.
  • Toxicology & Drug Monitoring: Used in pain management, emergency medicine, and substance abuse programs.
  • Autoimmune & Allergy: Emerging targets and expanded panels for systemic diseases.
  • Genetic Testing: Includes prenatal screening and gene expression profiling via immunoassay platforms.
  • Other Emerging Areas: Alzheimer’s disease, gastrointestinal disorders, transplant medicine, and women’s health (e.g., preeclampsia).

Analysis of Geographic Trends

  • Developed Markets:
    • North America and Western Europe dominate due to high healthcare infrastructure and adoption of advanced diagnostics.
    • Developed Asia Pacific also plays a key role.
  • Emerging Markets:
    • Immunoassays are key to expanding access in Latin America, Eastern Europe, Southeast Asia, and Africa, where centralized diagnostics are limited.
    • Lateral flow and self-testing are critical tools in resource-limited settings.

Scope and Methodology

This report presents the global immunoassay market in U.S. dollars, covering the years 2024 through 2029. It analyzes a wide range of immunoassay technologies, from high-throughput lab instruments to manual point-of-care (POC) tests, including rapid immunochromatographic or lateral flow formats.

The primary focus is on developed regions—North America, Western Europe, and developed Asia-Pacific—while also recognizing the importance of POC testing in expanding diagnostic access in underserved areas.

Market data reflects manufacturer revenue rather than retail prices or reimbursements. Segment values generally align with test volumes, as instrument costs are often bundled into per-test pricing.

A blend of primary and secondary research underpins the report’s findings. Secondary sources included public and proprietary databases, industry reports, regulatory filings, company publications, and peer-reviewed journals. These sources provided context, competitor identification, and strategic insights.

To validate and deepen the research, Kalorama conducted over 30 interviews with industry experts such as executives, product and marketing leaders, consultants, healthcare professionals, and government representatives. These interviews provided qualitative insights into market dynamics and trends.

Additional outreach to companies yielded specific figures on revenue, market share, and product performance. All data were verified against multiple sources and, when possible, triangulated using public disclosures, proprietary insights, and expert feedback.

Market sizing and forecasts are based on 2024 as the base year, with projections through 2029 supported by historical trends, demographic shifts, technological advances, and global market expansion. Competitive analysis reflects the landscape in 2024, with forward-looking trends identified for subsequent years

Chapter 1: Executive Summary

Overview

Scope and Methodology

Market Overview

  • Table 1-1: Global Immunoassay Market, 2024-2029 ($ million) [Lab-based, POC-based]
  • Figure 1-1: Global Immunoassay Market, 2024-2029 ($ million) [Lab-based, POC-based]
  • Figure 1-2: Global Immunoassay Market Share, 2024-2029 ($ million) [Lab-based, POC-based]

Competitive Summary

 

Chapter 2: Introduction

History and Future of Immunoassays

Immunoassay Technology Continues to Evolve

 

Chapter 3: Technology, Trends, and Innovations

Overview – Immunoassays

  • Table 3-1: Immunoassay Sensitivity, by Technology Type and Setting (Lab, POC) [CLIA, ELISA, FIA, IHC, LFIA, RIA]

Chemiluminescent Immunoassay (CLIA)

Enzyme-Linked Immunosorbent Assay (ELISA)

Fluoroimmunoassay (FIA)

Immunohistochemistry (IHC)

Lateral Flow Immunoassay (LFIA)

Radioimmunoassay (RIA)

Western Blotting

Immunoassay Technology Innovations and Emerging Trends

Overview – Instrument Platforms

Microtiter Plate-Based Immunoassays and Automation

Automation in Immunoassays

Platform Innovations: Miniaturization, Microfluidics, and Multiplexing

Point-of-Care (POC) and Miniaturized Devices

Lab-on-a-Chip (LOC) and Biochips

Case Example: Veravas VeraBIND Technology

  • Table 3-2: Selected Immunoassay Technologies

Specimen Types

Blood

Urine

Saliva

  • Table 3-3: Selected Companies with Saliva or Oral-Fluid Collection Devices

 

Chapter 4: Market Segment by Setting

Centralized Laboratories

  • Table 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2024 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
  • Figure 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2024 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
  • Figure 4-2: Global Lab-based Immunoassay Market Distribution, by Application Segment, 2024 (%) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]

Companies Marketing to Centralized Laboratories

  • Table 4-2: Selected Companies Marketing Central Lab-Based Immunoassays Worldwide

Rapid and Point-of-Care Testing

  • Table 4-3: Global POC-based Immunoassay Market, by Application Segment, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
  • Figure 4-3: Global POC-based Immunoassay Market, by Application Segment, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
  • Figure 4-4: Global POC-based Immunoassay Market Distribution, by Application, 2024 (%) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology, Toxicology, Other]

POC Testing in Hospitals

Physician’s Office Laboratories and Clinics

Retail Clinics

Other Professional POC Testing

Self-Testing

Companies Marketing Immunoassay for POC Testing

  • Table 4-4: Selected Companies Marketing Immunoassay and/or Lateral Flow Tests for POC Worldwide

 

Chapter 5: Immunoassay Diagnostic Market Activity by Application

  • Table 5-1: Immunoassay Market Disease Categories

Allergy

  • Figure 5-1: Global Allergy Immunoassay Market, 2024-2029 ($ million)
  • Table 5-2: Selected Companies Marketing Immunoassays for Allergy Diagnostics

Autoimmune Disease

  • Figure 5-2: Global Autoimmune Disease Immunoassay Market, 2024-2029 ($ million)
  • Table 5-3: Selected Autoantibodies Detected by Autoimmune Immunoassays

Cardiac Markers

  • Figure 5-3: Global Cardiac Marker Immunoassay Market, 2024-2029 ($ million)
  • Table 5-4: Selected Cardiac Marker Immunoassays
  • Table 5-5: Selected Cardiac Marker Innovations

Genetic Testing

  • Figure 5-4: Global Genetic Immunoassay Market, 2024-2029 ($ million)

Infectious Disease

  • Figure 5-5: Global Infectious Disease Immunoassay Market, 2024-2029 ($ million)

Lab-based Infectious Disease Immunoassays

  • Table 5-6: Global Lab-based Infectious Disease Immunoassay Sales, 2024 ($ million) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
  • Figure 5-6: Global Lab-based Infectious Disease Immunoassay Sales, 2024 ($ million) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
  • Figure 5-7: Global Lab-based Infectious Disease Immunoassay Market Share, 2024 (%) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]

Blood Screening

  • Table 5-7: Selected Infectious Disease Immunoassays
  • Table 5-8: Selected Companies Marketing Immunoassays for Infectious Disease

Hepatitis

Lyme Disease

Rapid and POC Testing

Retroviral

Sexually Transmitted Diseases

ToRCH

COVID-19

  • Table 5-9: Selected Antigen POC and Home Immunoassay Tests for SARS-CoV-2

Other Infectious Diseases

Metabolic Disorders and Other Hormones

  • Figure 5-8: Global Metabolic and Hormone Disorder Immunoassay Market, 2024-2029 ($ million)
  • Table 5-10: Selected Metabolic and Other Hormone Immunoassays

Fertility/Pregnancy/Reproductive Hormones

  • Table 5-11: Selected Fertility and Reproductive Hormone Immunoassays

Thyroid

  • Table 5-12: Selected Thyroid Hormone Immunoassays

Oncology – Tumor Markers

  • Figure 5-9: Global Oncology Immunoassay Market, 2024-2029 ($ million)

Lab-based Oncology Immunoassays

  • Table 5-13: Global Lab-based Tumor Marker Immunoassay Sales, 2024 ($ million) [AFP, CA-125, CEA, PSA, Others]
  • Figure 5-10: Global Lab-based Tumor Marker Immunoassay Sales, 2024 ($ million) [AFP, CA-125, CEA, PSA, Others]
  • Figure 5-11: Global Lab-based Tumor Marker Immunoassay Market Share, 2024 (%) [AFP, CA-125, CEA, PSA, Others]
  • Table 5-14: Selected Companies Marketing Immunoassays for Tumor Markers
  • Table 5-15: Selected Companies Marketing Metabolic Immunoassays

Toxicology

  • Figure 5-12: Global Toxicology Marker Immunoassay Market, 2024-2029 ($ million)

Drugs of Abuse

  • Table 5-16: Selected Drugs of Abuse Immunoassays

Therapeutic Drug Monitoring

  • Table 5-17: Selected Therapeutic Drug Monitoring Immunoassays

Other Disease Categories in Immunoassay Disease Market

  • Figure 5-13: Other Immunoassay Market, 2024-2029 ($ million)
  • Table 5-18: Selected Other Immunoassays

 

Chapter 6: Market Opportunities and Issues for Immunoassays

Immunoassay Market – Overview

Immunoassay Market Drivers and Challenges

Drivers

New and Emerging Areas of Immunoassay Innovation

Gastrointestinal Disorders

  • Table 6-1: Selected Inflammatory Bowel Disease Test Innovations

Transplant Management

  • Table 6-2: Selected Immunoassays for Transplant Medicine

Preeclampsia

  • Table 6-3: Selected Women’s Health Innovations

Alzheimer’s Disease

  • Table 6-4: Selected Innovations for Alzheimer’s Disease Immunoassays
  • Table 6-5: Selected Immunoassay Innovations

Emerging International Markets

  • Table 6-6: Selected Companies Outside of North America, Europe, or Japan Marketing Immunoassays

Lab-Developed Tests

Staffing Shortages

Outlook for Immunoassays

 

Chapter 7: Immunoassay Market Analysis

Market Overview and Market Segments

  • Table 7-1: Global Immunoassay Market, by Laboratory Setting, 2024-2029 ($ million) [Lab-based, POC-based]
  • Figure 7-1: Global Immunoassay Market, by Laboratory Setting, 2024-2029 ($ million) [Lab-based, POC-based]
  • Figure 7-2: Global Immunoassay Market Segment Share, by Laboratory Setting, 2024 (%) [Lab-based, POC-based]

Central Lab-based Immunoassay Market

  • Table 7-2: Global Lab-based Immunoassay Market, by Application, 2024-2029 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Other]
  • Figure 7-3: Global Lab-based Immunoassay Market, by Application, 2024-2029 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Other]

Point of Care/Rapid Test Immunoassays by Disease Category

  • Table 7-3: Global POC Immunoassay Market Analysis, by Disease Category, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
  • Figure 7-4: Global POC Immunoassay Market Analysis, by Disease Category, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
  • Figure 7-5 Global POC Immunoassay Market Analysis, by Disease Category Market Share, 2024 (%) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]

Immunoassay Market by Technology Type

  • Table 7-4: Global Immunoassay Market, by Technology Segment, 2024-2029 ($ million) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
  • Figure 7-6: Global Immunoassay Market, by Technology Segment, 2024-2029 ($ million) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
  • Table 7-5: Global Immunoassay Market Share, by Technology Segment, 2024 (%) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
  • Figure 7-7: Global Immunoassay Market Share, by Technology Segment, 2024 (%) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]

Competitive Analysis

  • Table 7-6: Global Immunoassay Market Analysis, by Competitor Revenues ($ million) and Market Share (%), 2024 [Abbott, Becton Dickinson, Bio-Rad, bioMérieux, Bruker – CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
  • Figure 7-8: Global Immunoassay Market Analysis, by Competitor Revenues ($ million), 2024 [Abbott, Becton Dickinson, Bio-Rad, bioMérieux, Bruker – CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
  • Figure 7-9: Global Immunoassay Market Analysis, by Competitor Market Share, 2024 (%) [Abbott, Becton Dickinson, Bio-Rad, bioMérieux, Bruker – CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]

Immunoassay Market by Geographic Regions

  • Table 7-7: Immunoassay Market, by Geographic Region, 2024-2029 ($ million) [Asia Pacific, Europe, North America, Rest of World]
  • Figure 7-10: Immunoassay Market, by Geographic Region, 2024-2029 ($ million) [Asia Pacific, Europe, North America, Rest of World]
  • Figure 7-11: Immunoassay Market Share, by Geographic Region, 2024 (%) [Asia Pacific, Europe, North America, Rest of World]

North America

Europe

  • Table 7-8: Immunoassay Market, by European Geographic Region, 2024 ($ million) [France, Germany, Italy, Spain, United Kingdom, Others]
  • Figure 7-12: Immunoassay Market, by European Geographic Region, 2024 ($ million) [France, Germany, Italy, Spain, United Kingdom, Others]
  • Figure 7-13: Immunoassay Market Share, by European Geographic Region, 2024 (%) [France, Germany, Italy, Spain, United Kingdom, Others]

Asia Pacific

  • Table 7-9: Immunoassay Market, by Asia Pacific Geographic Region, 2024 ($ million) [China, India, Japan, Others]
  • Figure 7-14: Immunoassay Market, by Asia Pacific Geographic Region, 2024 ($ million) [China, India, Japan, Others]
  • Figure 7-15: Immunoassay Market Share, by Asia Pacific Geographic Region, 2024 (%) [China, India, Japan, Others]

Rest of World

  • Table 7-10: Immunoassay Market, by Rest of World Geographic Region, 2024 ($ million) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
  • Figure 7-16: Immunoassay Market, by Rest of World Geographic Region, 2024 ($ million) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
  • Figure 7-17: Immunoassay Market Share, by Rest of World Geographic Region, 2024 (%) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]

 

Chapter 8: Company Profiles

1 Step Detect Associates, LLC

  • Table 8-1: 1-Step Detect Associates Corporate Summary

Company Overview

Products

Abbott Laboratories

  • Table 8-2: Abbott Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-3: Abbott Revenues, 2023-2024 ($millions)

Abingdon Health, Ltd.

  • Table 8-4: Abingdon Health Corporate Summary

Company Overview

Products

Access Bio, Inc.

  • Table 8-5: Access Bio Summary

Company Overview

Products

AccuBioTech Co, Ltd.

  • Table 8-6: AccuBioTech Corporate Summary

Company Overview

Products

ACON Laboratories, Inc

  • Table 8-7: ACON Laboratories Corporate Summary

Company Overview

Products

AESKU. DIAGNOSTICS

  • Table 8-8: AESKU.DIAGNOSTICS Corporate Summary

Company Overview

Products

Aidian Oy

  • Table 8-9: Aidian Corporate Summary

Company Overview

Products

Alfa Scientific Designs, Inc

  • Table 8-10: Alfa Scientific Design

Company Overview

Products

American Laboratory Products Company (ALPCO)

  • Table 8-11: American Laboratory Products Corporate Summary

Company Overview

Products

Anbio Biotechnology

  • Table 8-12: Anbio Biotechnology Corporate Summary

Company Overview

Products

ARKRAY, Inc

  • Table 8-13: ARKRAY Corporate Summary

Company Overview

Products

Arlington Scientific, Inc.

  • Table 8-14: Arlington Scientific Corporate Summary

Company Overview

Products

Artron Laboratories Inc.

  • Table 8-15: Artron Laboratories Corporate Summary

Company Overview

Products

Associates of Cape Cod, Inc. (ACC)

  • Table 8-16: Associates of Cape Cod Corporate Summary

Company Overview

Products

Autobio Diagnostics Co., Ltd

  • Table 8-17: Autobio Diagnostics Corporate Summary

Company Overview

Products

Avioq, Inc.

  • Table 8-18: Avioq Corporate Summary

Company Overview

Products

Awareness Technology

  • Table 8-19: Awareness Technology Corporate Summary

Company Overview

Products

Beckman Coulter, Inc

  • Table 8-20: Beckman Coulter Corporate Summary

Company Overview

Products

Becton Dickinson (BD)

  • Table 8-21: BD Corporate Summary

Company Overview

Products

Company Financials

  • Table 8-22: BD Corporation Revenue, 2023-2024 ($ million)

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

  • Table 8-23: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary

Company Overview

Products

Bhat Bio-Tech India Private Ltd. (BBI)

  • Table 8-24: Bhat Bio-Tech India Private Corporate Summary

Company Overview

Products

BioCheck, Inc.

  • Table 8-25: BioCheck Corporate Summary

Company Overview

Products

Biohit Oyj (Biohit Healthcare)

  • Table 8-26: Biohit Oyj Corporate Summary

Company Overview

Products

bioLytical Laboratories

  • Table 8-27: bioLytical Laboratories Corporate Summary

Company Overview

Products

BioMedomics, Inc.

  • Table 8-28: BioMedomics Corporate Summary

Company Overview

Products

Biomerica

  • Table 8-29: Biomerica Summary

Company Overview

Products

Company Financials

  • Table 8-30: Biomerica Corporation Revenue, 2023-2024 ($ million)

bioMérieux SA

  • Table 8-31: bioMérieux SA Corporate Summary

Company Overview

Products

Company Financials

  • Table 8-32: bioMérieux Revenues, 2023-2024 (€ millions)

BioPorto Diagnostics

  • Table 8-33: BioPorto Diagnostics Corporate Summary

Company Overview

Products

Company Financials

  • Table 8-34: BioPorto Diagnostics Revenues, 2023-2024 (DKK millions)

Bio-Rad Laboratories Inc.

  • Table 8-35: Bio-Rad Labs Corporate Summary

Company Overview

Products

Company Financials

  • Table 8-36: Bio-Rad Corporation Revenue, 2023-2024 ($ million)

Bioscience (Tianjin) Diagnostic Technology Co., Ltd.

  • Table 8-37: Bioscience (Tianjin) Diagnostic Technology Corporate Summary

Company Overview

Products

Bio-Techne

  • Table 8-38: Bio-Techne Corporate Summary

Company Overview

Products

Company Financials

  • Table 8-39: Bio-Techne, 2023-2024 ($ million)

Biotron Diagnostics, Inc.

  • Table 8-40: Biotron Diagnostics Corporate Summary

Company Overview

Products

Boditech Med Inc.

  • Table 8-41: Boditech Med Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-42: Boditech Med Revenues 2023-2024 (KRW billion)

Boson Biotech Co. Ltd

  • Table 8-43: Boson Biotech Corporate Summary

Company Overview

Products

BUHLMANN Laboratories AG

  • Table 8-44: BUHLMANN Laboratories Summary

Company Overview

Products

Certest Biotec

  • Table 8-45: Certest Biotec Summary

Company Overview

Products

Chembio Diagnostic Systems, Inc.

  • Table 8-46: Chembio Diagnostic Corporate Summary

Company Overview

Products

Clarity Diagnostics, LLC

  • Table 8-47: Clarity Diagnostics Corporate Summary

Company Overview

Products

Confirm Biosciences

  • Table 8-48: Confirm Biosciences Corporate Summary

Company Overview

Products

CTK Biotech, Inc.

  • Table 8-49: CTK Biotech Corporate Summary

Company Overview

Products

Diagenics Group SE

  • Table 8-50: Diagenics Group Corporate Summary

Company Overview

Products

DIALAB GmbH

  • Table 8-51: DIALAB Summary

Company Overview

Products

Diametra

  • Table 8-52: Diametra Corporate Summary

Company Overview

Products

DiaSorin S.p.A.

  • Table 8-53: DiaSorin Corporate Summary

Company Overview

Products

Company Financials

  • Table 8-54: DiaSorin 2023-2024 (€ thousand)

DiaSource ImmunoAssays SA

  • Table 8-55: DiaSource ImmunoAssays Corporate Summary

Company Overview

Products

DiaSys Diagnostic Systems GmbH (Mindray)

  • Table 8-56: DiaSys Diagnostic Systems Corporate Summary

Company Overview

Products

Diazyme Laboratories, Inc.

  • Table 8-57: Diazyme Laboratories Corporate Summary

Company Overview

Products

Dr. Fooke-Achterrath Laboratorien GmbH

  • Table 8-58: Dr. Fooke-Achterrath Laboratorien Corporate Summary

Company Overview

Products

Eiken Chemical Co Ltd.

  • Table 8-59: Eiken Chemical Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-60: Eiken Chemical Revenues, 2023-2024 (million yen)

EKF Diagnostics Holdings plc

  • Table 8-61: EKF Diagnostics Corporate Summary

Company Overview

Products

ELITechGroup S.A.S.

  • Table 8-62: ELITechGroup Corporate Summary

Company Overview

Products

Eurobio Scientific

  • Table 8-63: Eurobio Scientific Corporate Summary

Company Overview

Products

Eurospital Spa

  • Table 8-64: Eurospital Summary

Company Overview

Products

EY Laboratories

  • Table 8-65: EY Laboratories Summary

Company Overview

Products

Fujirebio-US, Inc.

  • Table 8-66: Fujirebio Corporate Summary

Company Overview

Products

GenBio

  • Table 8-67: GenBio Corporate Summary

Company Overview

Products

Gold Standard Diagnostics

  • Table 8-68: Gold Standard Diagnostics Corporate Summary

Company Overview

Products

Grifols International S.A.

  • Table 8-69: Grifols International S.A. Corporate Summary

Company Overview

Products

Company Financials

  • Table 8-70: Grifols Revenue, 2023-2024 (€ million)

Hemosure, Inc.

  • Table 8-71: Hemosure Corporate Summary

Company Overview

Products

HYCOR Biomedical, Inc.

  • Table 8-72: HYCOR Biomedical Corporate Summary

Company Overview

Products

Immuno-Mycologics, Inc.

  • Table 8-73: Immuno-Mycologics Corporate Summary

Company Overview

Products

Immunosciences Lab, Inc.

  • Table 8-74: Immunosciences Lab Corporate Summary

Company Overview

Products

Immunostics, Inc

  • Table 8-75: Immunostics Corporate Summary

Company Overview

Products

InBios International, Inc.

  • Table 8-76: InBios Corporate Summary

Company Overview

Products

JAL Innovation PTE LTD

  • Table 8-77: JAL Innovation Corporate Summary

Company Overview

Products

Jant Pharmacal Corporation

  • Table 8-78: Jant Pharmacal Summary

Company Overview

Products

  1. Mitra & Co Pvt. Ltd
  • Table 8-79: J Mitra Corporate Summary

Company Overview

Products

KRONUS

  • Table 8-80: KRONUS Corporate Summary

Company Overview

Products

Kypha

  • Table 8-81: Kypha Corporate Summary

Company Overview

Products

Labsystems Diagnostics Oy

  • Table 8-82: Labsystems Diagnostics Corporate Summary

Company Overview

Products

LamdaGen Corporation

  • Table 8-83: LamdaGen Corporate Summary

Company Overview

Products

LifeSign, LLC

  • Table 8-84: LifeSign Summary

Company Overview

Products

Macherey-Nagel GmbH & Co. KG

  • Table 8-85: Macherey-Nagel Corporate Summary

Company Overview

Products

Medix Biochemica

  • Table 8-86: Medix Biochemica Summary

Company Overview

Products

MedMira, Inc

  • Table 8-87: MedMira Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-88: MedMira, Revenues 2023-2024 ($ thousands)

Mercodia AB

  • Table 8-89: Mercodia AB Summary

Company Overview

Products

Meridian BioScience, Inc

  • Table 8-90: Meridian BioScience Corporate Summary

Company Overview

Products

Monobind, Inc

  • Table 8-91: Monobind Corporate Summary

Company Overview

Products

Nano-Ditech Corporation

  • Table 8-92: Nano-Ditech Corporate Summary

Company Overview

Products

Nexus Dx Inc

  • Table 8-93: Nexus Dx Corporate Summary

Company Overview

Products

Nova Biomedical, Corp.

  • Table 8-94: Nova Biomedical Corporate Summary

Company Overview

Products

Oasis Diagnostics Corporation

  • Table 8-95: Oasis Diagnostics Corporate Summary

Company Overview

Products

Operon

  • Table 8-96: Operon Corporate Summary

Company Overview

Products

OPKO Health, Inc

  • Table 8-97: OPKO Health Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-98: OPKO Health Revenues, 2023-2024 ($ million)

OraSure Technologies, Inc.

  • Table 8-99: OraSure Technologies Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-100: OraSure Revenues, 2023-2024 ($ million)

PixCell Medical Technologies

  • Table 8-101: PixCell Corporate Summary

Company Overview

Products

Polymedco, Inc

  • Table 8-102: Polymedco Corporate Summary

Company Overview

Products

Precision Biosensor

  • Table 8-103: Precision Biosensor Corporate Summary

Company Overview

Products

Preventis GmbH

  • Table 8-104: Preventis Corporate Summary

Company Overview

Products

Princeton Biomeditech Corporation

  • Table 8-105: Princeton Biomeditech Corporate Summary

Company Overview

Products

PTS Diagnostics

  • Table 8-106: PTS Corporate Summary

Company Overview

Products

Qualigen, Inc.

  • Table 8-107: Qualigen Corporate Summary

Company Overview

Products

Quanterix Corporation

  • Table 8-108: Quanterix Corporate Summary

Company Overview

Products

QuidelOrtho Corporation

  • Table 8-109: QuidelOrtho Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-110: QuidelOrtho Revenues, 2023-2024 ($ million)

Radiometer Medical A/S

  • Table 8-111: Radiometer Medical Corporate Summary

Company Overview

Products

Response Biomedical Corp

  • Table 8-112: Response Biomedical Corporate Summary

Company Overview

Products

Reszon Diagnostics International Sdn. Bhd.

  • Table 8-113: Reszon Diagnostics Corporate Summary

Company Overview

Products

Revvity

  • Table 8-114: Revvity Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-115: Revvity Revenues, 2023-2024 ($ million)

Roche Diagnostic Corporation

  • Table 8-116: Roche Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-117: Roche Diagnostics Revenue, 2023-2024 (CHF millions)

Savyon Diagnostics Ltd.

  • Table 8-118: Savyon Diagnostics Summary

Company Overview

Products

Sekisui Diagnostics LLC

  • Table 8-119: Sekisui Diagnostics Corporate Summary

Company Overview

Products

Siemens Healthineers

  • Table 8-120: Siemens Healthineers Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-121: Siemens Healthineers Revenue, 2023-2024 (€ millions)

Syntron Bioresearch, Inc.

  • Table 8-122: Syntron Bioresearch Corporate Summary

Company Overview

Products

Sysmex Corporation

  • Table 8-123: Sysmex Corporate Summary

Company Overview

Products

Performance Review

  • Table 8-124: Sysmex Revenues, 2023-2024 (billion yen)

TECHLAB, Inc.

  • Table 8-125: TECHLAB Corporate Summary

Company Overview

Products

Teco Diagnostics

  • Table 8-126: Teco Diagnostics Corporate Summary

Company Overview

Products

Thermo Fisher Scientific, Inc

  • Table 8-127: Thermo Fisher Scientific Corporate Summary

Company Overview

Products

Company Financials

  • Table 8-128: Thermo Fisher Scientific Revenues, 2023-2024 ($ million)

Tosoh Bioscience, Inc.

  • Table 8-129: Tosoh Bioscience Corporate Summary

Company Overview

Products

Company Financials

  • Table 8-130: Tosoh Corporation Revenue, 2023-2024 (billion yen)

Trinity Biotech PLC

  • Table 8-131: Trinity Biotech Corporate Summary

Company Overview

Products

True Diagnostics

  • Table 8-132: True Diagnostics Corporate Summary

Company Overview

Products

VedaLab

  • Table 8-133: VedaLab Corporate Summary

Company Overview

Products

Vircell

  • Table 8-134: Vircell Corporate Summary

Company Overview

Products

WAMA Diagnostica

  • Table 8-135: WAMA Diagnostica Corporate Summary

Company Overview

Products

Werfen Group

  • Table 8-136: Werfen Group Corporate Summary

Company Overview

Products

Zeus Scientific, Inc.

  • Table 8-137: Zeus Scientific Corporate Summary

Company Overview

Products

 

Our Knowledge Center provides access to

all market reports